Cryptosporidium hominis

Source: Wikipedia, the free encyclopedia.

Cryptosporidium hominis
Scientific classification Edit this classification
Domain: Eukaryota
Clade: Diaphoretickes
Clade: SAR
Clade: Alveolata
Phylum: Apicomplexa
Class: Conoidasida
Order: Eucoccidiorida
Family: Cryptosporidiidae
Genus: Cryptosporidium
Species:
C. hominis
Binomial name
Cryptosporidium hominis
Morgan-Ryan, Fall, Ward, Hijjawi, Sulaiman, Fayer, Thompson, Olson, Lal and Xiao, 2002

Cryptosporidium hominis, along with

oocyst laden feces.[2] There are many exposure risks that people can encounter in affected areas of the world. Cryptosporidium infections are large contributors of child death and illness in heavily affected areas, yet low importance has been placed on both identifying the species and finding more treatment options outside of nitazoxanide for children and AIDS patients.[3]

Characteristics

Cryptosporidium hominis shares many similar characteristics with C. parvum including identical oocyst morphology and life-cycle. The different cryptosporidium species share nearly identical morphological features, so differentiation is only seen at the molecular level.[4] As a result, C. hominis is most easily differentiated from C. parvum through genetic analysis via time-intensive PCR-restriction fragment length polymorphism or gene sequencing.[5]

Life cycle

The

gametogony forming micro and macrogametocytes. The gametocytes can then fuse, forming a zygote, which starts the cycle again.[citation needed
]

Treatment

Though symptoms in most immunocompetent persons will resolve without treatment,

immunocompromised patients, however, is uncertain and current treatments revolve around boosting the host immune system to aid in symptom resolution.[6] Current avenues for treatment include scanning the Cryptosporidium hominis genome for possible targets for vaccine development.[7]

References